Cutter Capital Management, LP Portfolio Holdings
Cutter Capital Management, LP
- $339 Billion
- Q3 2024
Cutter Capital Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $339 Billion distributed in 27 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Gilead Sciences, Inc. with a value of $30.1B, Bristol Myers Squibb CO with a value of $29.7B, Royalty Pharma PLC with a value of $18.8B, Agilent Technologies, Inc. with a value of $17.9B, and Ultragenyx Pharmaceutical Inc. with a value of $15.9B.
Examining the 13F form we can see an increase of $7.5B in the current position value, from $331B to 339B.
Cutter Capital Management, LP is based out at New York, NY
Below you can find more details about Cutter Capital Management, LP portfolio as well as his latest detailed transactions.